{"id":168418,"date":"2025-05-19T06:38:14","date_gmt":"2025-05-19T10:38:14","guid":{"rendered":"https:\/\/44.250.171.167\/?p=168418"},"modified":"2025-05-19T06:38:14","modified_gmt":"2025-05-19T10:38:14","slug":"alembic-pharmaceuticals-ltd-q4fy25-12-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q4fy25-12-fall-in-profits\/","title":{"rendered":"Alembic Pharmaceuticals Ltd Q4FY25; 12% fall in Profits"},"content":{"rendered":"<p>Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.<br \/>\nThe company has 3 R&amp;D and 5 manufacturing facilities.<\/p>\n<p>Financial Results:<\/p>\n<p>Alembic Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b91,770.00 Crores up from \u20b91,517.00 Crore year on year, a rise of 16.68%.<\/p>\n<p>Total Expenses for Q4FY25 of \u20b91,592.00 Crores up from \u20b91,337.00 Crores year on year, a rise of 19.07%.<\/p>\n<p>Consolidated Net Profit of \u20b9157.00 Crores down 11.8% from \u20b9178.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b97.98, down 12.02% from \u20b99.07 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-168419\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&amp;D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b91,770.00 Crores up from \u20b91,517.00 Crore year on year, a rise of 16.68%. Total Expenses for [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":168419,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-168418","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165765,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q2fy25-12-rise-in-profits\/","url_meta":{"origin":168418,"position":0},"title":"Alembic Pharmaceuticals Ltd Q2FY25; 12% rise in Profits","author":"Divyansh_Kasana","date":"November 21, 2024","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q2FY25 of \u20b91,648.00 Crores up from \u20b91,595.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167021,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q3fy25-23-fall-in-profits\/","url_meta":{"origin":168418,"position":1},"title":"Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits","author":"Divyansh_Kasana","date":"February 21, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b91,693.00 Crores up from \u20b91,631.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151180,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q1fy24-18-rise-in-revenue\/","url_meta":{"origin":168418,"position":2},"title":"Alembic Pharmaceuticals Ltd Q1FY24; 18% rise in Revenue.","author":"Divyansh_Kasana","date":"August 4, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b91,486.00 Crores up from \u20b91,262.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159293,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q3fy24-48-rise-in-profits\/","url_meta":{"origin":168418,"position":3},"title":"Alembic Pharmaceuticals Ltd Q3FY24; 48% rise in Profits","author":"Divyansh_Kasana","date":"February 28, 2024","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q3FY24 of \u20b91,631.00 Crores up from \u20b91,509.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-242.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-242.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-242.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-242.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-242.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-242.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157523,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q2fy24-3-rise-in-profits\/","url_meta":{"origin":168418,"position":4},"title":"Alembic Pharmaceuticals Ltd Q2FY24; 3% rise in Profits","author":"Divyansh_Kasana","date":"December 21, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b91,595.00 Crores up from \u20b91,475.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152547,"url":"https:\/\/alphastreet.com\/india\/alembic-ltd-q1fy24-68-rise-in-revenue\/","url_meta":{"origin":168418,"position":5},"title":"Alembic Ltd Q1FY24; 68% rise in Revenue","author":"Divyansh_Kasana","date":"August 10, 2023","format":false,"excerpt":"Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=168418"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168418\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/168419"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=168418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=168418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=168418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}